Navigation Links
Off-Label Use of Clotting Drug Soars, Report Finds
Date:4/18/2011

MONDAY, April 18 (HealthDay News) -- Hospitals are using a pricey blood-clotting drug in treating people who do not have hemophilia, a rare disorder in which blood does not clot normally -- even though its use in such patients is potentially risky, according to new research.

Stanford University researchers found that use of the drug, known as recombinant factor 7a, grew by 140 times from use in 125 cases in 2000 to 17,813 in 2008, with off-label uses accounting for most of the increase.

The $10,000-a-dose drug was used in people with hemophilia just 4 percent of the time, according to U.S. hospital statistics from 2000 to 2008. The rest of the time, it was used during heart surgery and to treat medical problems such as trauma and bleeding in the brain. The researchers content that such use puts patients at risk for heart attack and stroke because the drug can boost the risk of blood clots.

"The stakes are high with this one," Dr. Veronica Yank, an instructor in medicine at Stanford and the first author of one of two new studies on the drug, said in a university news release. "Because it's such a powerful clotting agent, it has the potential when used off-label to damage the lives of patients without providing any real benefit."

Yank and her colleagues said that physicians should be more cautious with the drug until there's more research into whether it's appropriate to use in certain cases.

The studies, published April 19 in Annals of Internal Medicine, are accompanied by a commentary from Harvard Medical School researchers, which says the research provides "compelling data about the runaway use, uselessness and risk for this expensive treatment."

The studies were funded by the U.S. Agency for Healthcare Quality and Research after previous research raised concerns that RF7a increased the risk for blood clots. The agency asked for an assessment of five off-label uses of RF7a: heart surgery, intracranial hemorrhage, body and brain trauma, liver transplantation and prostate surgery.

More information

The U.S. National Heart, Lung and Blood Institute has more on hemophilia.

-- Randy Dotinga

SOURCE: Stanford University School of Medicine, news release, April 18, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Hemophilia Drug Used Off-Label Raises Clot Risk
2. Anti-clotting agent does not improve outcomes of patients with severe pneumonia
3. New Anti-Clotting Drug May Work Better After Hip Replacement
4. Extended use of anti-clotting drug helps some bedridden patients
5. Tests to Measure Safety of Anti-Clotting Drugs of Limited Value
6. TBI Therapy and Nutrition: IOM report releases April 20
7. Boston University researchers find most substance-dependent individuals report poor oral health
8. Making temporary changes to brain could speed up learning, study reports
9. Aerobic Exercise May Curb Non-Alcoholic Fatty Liver Disease: Report
10. Brisk Walk Can Boost Blood Flow to the Brain: Report
11. U.S. Reports Drop in AIDS-Related Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Off-Label Use of  Clotting Drug Soars, Report Finds
(Date:1/12/2020)... ... January 12, 2020 , ... ... in New York City, has continually innovated for over a decade to transform ... and medical device companies and self-insured employers. By optimizing the mix of expert ...
(Date:1/10/2020)... (PRWEB) , ... January 10, 2020 , ... ... the complexities of autoimmune conditions, HMP, a leading healthcare event and education company, ... help improve patient care. , The Autoimmune Learning Network serves as a robust ...
(Date:1/8/2020)... ... January 08, 2020 , ... Pyxa Solutions, a ... today that the company is rebranding as Red Nucleus R&D, a division of ... for the life sciences industry. , The addition of Red Nucleus R&D ...
(Date:1/7/2020)... ... January 07, 2020 , ... ... develops tools for characterizing microbiome populations down to the strain level, has ... Japanese biotech organization. , TOMY provides high-quality instruments and services to industry ...
(Date:1/7/2020)... ... , ... CBD For The People was created with the belief ... individual customer service experience. Transparency and integrity are the core of this company. CBD ... care of the people first, they know that satisfied customers will bring back more ...
Breaking Medicine News(10 mins):
(Date:1/3/2020)... ... January 03, 2020 , ... In Partnership with the Smiles ... low-income, underinsured individuals at its Burleson, TX office on February 8th. , Dental services ... cleanings and extractions . For more information, please visit the ...
(Date:1/2/2020)... ... ... In an age of the current mental health crisis, it’s a lesson ... embrace acceptance and understanding of the needs of atypical’s that are one of the ... a new story that represents the Children’s First Mental Health Primer. Come aboard to ...
(Date:12/31/2019)... (PRWEB) , ... December 31, 2019 , ... ... on addressing unmet needs in the field of urology, today announced that Dr. ... designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Daily ...
Breaking Medicine Technology: